Drug intelligence / Profile preview

lamivudine + ursolic acid

Development stage: Preclinical
Modality: Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Small Molecules
Administration: Oral, Intravenous

Overview

LMX is an experimental codrug and liposomal formulation that combines the antiviral nucleoside analog lamivudine with the pentacyclic triterpenoid ursolic acid. It is designed for the treatment of Hepatitis B Virus (HBV) infection, aiming to provide a dual therapeutic effect: lamivudine acts as a potent inhibitor of HBV DNA polymerase/reverse transcriptase to suppress viral replication, while ursolic acid provides hepatoprotective and anti-inflammatory benefits to mitigate acute liver injury. The compound is typically formulated in liposomal preparations to enhance the bioavailability and liver-targeting efficiency of the two active moieties. Research has explored its administration via both oral and intravenous routes to optimize therapeutic outcomes in chronic hepatitis B management.

Other names: Lamivudine-ursolic acid codrugLMX liposomes

Targets

HBV Pol (Hepatitis B virus polymerase)

Beyond the preview

Go deeper on lamivudine + ursolic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on lamivudine + ursolic acid.

Explore the full profile